National Human Genome Research Institute; Notice of Closed Meetings, 56028 [2023-17741]
Download as PDF
<![CDATA[
56028
Federal Register / Vol. 88, No. 158 / Thursday, August 17, 2023 / Notices
sector to develop a vaccine directed
against nicotine or a related molecule
called arecoline, with the goal of
reducing or eliminating the craving of
such substance(s) in smokers or betel
nut users.
FOR FURTHER INFORMATION CONTACT:
Inquiries relating to this collaboration
opportunity should be directed to:
Michael Pollack, Ph.D., Supervisory
Technology Transfer Manager, NCI
Technology Transfer Center, 9609
Medical Center Drive, Room 1E530,
Rockville, MD 20850 (for overnight
mail) or Bethesda, MD 20892 (for
regular mail), Telephone: (240) 276–
5530; Facsimile: (240) 276–5504; Email:
pollackm@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The NCI
has expertise in the latest technology of
vaccine development and agents to
enhance immune responses to vaccines,
and NCI has the ability to participate in
vaccine preclinical and clinical studies.
The NCI is seeking a partner with
expertise in this area of anti-smoking
research and development.
Dated: August 11, 2023.
Richard U. Rodriguez,
Associate Director, Technology Transfer
Center, National Cancer Institute.
[FR Doc. 2023–17672 Filed 8–16–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; T32 Genomic Training.
Date: October 31, 2023.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Human Genome Research Institute,
VerDate Sep<11>2014
21:36 Aug 16, 2023
Jkt 259001
6700B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Suite 3000, Bethesda, MD 20892, (301) 594–
4280, mckenneyk@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; R25 Data Science meeting.
Date: November 8, 2023.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Human Genome Research Institute,
6700B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Sarah Jo Wheelan, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute for Human
Genome Research, National Institutes of
Health, 6700B Rockledge Drive, Room 3180,
Bethesda, MD 20892, (301) 402–8823,
wheelansj@nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; R25 Genome Research
Undergraduates—R25 ELM Training Modules
Genomics Research.
Date: December 1, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Human Genome Research Institute,
6700B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Suite 3000, Bethesda, MD 20892, (301) 594–
4280, mckenneyk@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: August 14, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–17741 Filed 8–16–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental and
Craniofacial Research; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Dental
and Craniofacial Research Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: September 12–13, 2023.
Closed: September 12, 2023, 4:45 p.m. to
6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Closed: September 13, 2023, 9:00 a.m. to
10:00 a.m.
Agenda: To review and evaluate BSC
report to Council.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Open: September 13, 2023, 10:00 a.m. to
3:30 p.m.
Agenda: Report of the Director, NIDCR and
concept clearances.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Lynn M. King, Ph.D.
Director, Division of Extramural Activities,
National Institute of Dental and Craniofacial
Research, 6701 Democracy Blvd., Room 960,
Bethesda, MD 20892–4878, (301) 594–5006,
Lynn.King@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about-us/advisorycommittees/advisory-council, where an
E:\FR\FM\17AUN1.SGM
17AUN1
]]>Agencies
[Federal Register Volume 88, Number 158 (Thursday, August 17, 2023)]
[Notices]
[Page 56028]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17741]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; T32 Genomic Training.
Date: October 31, 2023.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Human Genome
Research Institute, 6700B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Keith McKenney, Ph.D., Scientific Review
Officer, National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 3000, Bethesda,
MD 20892, (301) 594-4280, [email protected].
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; R25 Data Science meeting.
Date: November 8, 2023.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Human Genome
Research Institute, 6700B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Sarah Jo Wheelan, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute for Human
Genome Research, National Institutes of Health, 6700B Rockledge
Drive, Room 3180, Bethesda, MD 20892, (301) 402-8823,
[email protected].
Name of Committee: National Human Genome Research Institute
Special Emphasis Panel; R25 Genome Research Undergraduates--R25 ELM
Training Modules Genomics Research.
Date: December 1, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Human Genome
Research Institute, 6700B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Keith McKenney, Ph.D., Scientific Review
Officer, National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 3000, Bethesda,
MD 20892, (301) 594-4280, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: August 14, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-17741 Filed 8-16-23; 8:45 am]
BILLING CODE 4140-01-P
